Network origin in Paul A. Wender first degree
Entity | Entity type | Industry | |
---|---|---|---|
Bryologyx, Inc.
Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Bryologyx, Inc. operates as a biopharmaceutical company focused on treating cancer immunotherapies. The company was founded by Thomas M. Loarie, John H. Abeles, Paul A. Wender and Sam Kongsamut and is headquartered in Danville, CA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Paul A. Wender via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ABAXIS INC | Medical Specialties | Chief Executive Officer | |
TRINITY BIOTECH PLC | Medical Specialties | Director/Board Member | |
Northlea Partners LLLP | Corporate Officer/Principal | ||
LXN Corp
LXN Corp Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, LXN Corp is a company that develops and commercializes fructosamine monitoring technology for diabetes. The company is based in San Diego, CA. The company was founded by John F. Burd. LXN was acquired by Inverness Medical Technology, Inc. on March 29, 2001 for $18.48 million. | Pharmaceuticals: Major | Director/Board Member | |
CUTERA, INC. | Medical Specialties | Director/Board Member | |
RESPONSE BIOMEDICAL CORP | Miscellaneous Commercial Services | Director/Board Member | |
ChemBridge Corp.
ChemBridge Corp. BiotechnologyHealth Technology ChemBridge Corp. is a private company that engages in the research, development, and production of chemical products. The company is based in San Diego, CA. The company was founded by Nelson L. Levy. | Biotechnology | Founder | |
University of Notre Dame | College/University | Undergraduate Degree | |
NEUROTROPE, INC. | Pharmaceuticals: Major | Chairman | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree | |
MAST Immunosystems, Inc.
MAST Immunosystems, Inc. Medical SpecialtiesHealth Technology Part of Resonac Holdings Corp., MAST Immunosystems, Inc. is a company that develops innovative medical diagnostics and equipment. The company is based in Mountain View, CA. MAST Immunosystems was acquired by Resonac Corp., part of Resonac Holdings Corp. from 2020-04-20 on 1996-11-04 for $40.0 million. | Medical Specialties | President | |
Novacor, Inc.
Novacor, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Medtronic Plc, Novacor, Inc. is an American company that develops artificial heart and related technologies. The company is based in CA. Novacor was acquired by World Heart Corp., a subsidiary of Medtronic Plc from Edwards Lifesciences Corp. on June 30, 2000 for $58 million. | Miscellaneous Commercial Services | Chief Operating Officer | |
Yale University | College/University | Undergraduate Degree | |
Minot State University | College/University | Undergraduate Degree | |
University of Birmingham | College/University | Doctorate Degree | |
Mercator MedSystems, Inc.
Mercator MedSystems, Inc. Medical SpecialtiesHealth Technology Mercator MedSystems, Inc. develops medical injection devices. The firm focuses on the treatment of peripheral artery disease using its catheter-guided, micro-infusion systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel. It offers bullfrog micro-infusion device and blowfish trans-bronchial micro-infusion device. The company was founded by Kirk Patrick Seward, Michael Vestel, and Albert P. Pisano in 2000 and is headquartered in Emeryville, CA. | Medical Specialties | Chief Executive Officer | |
zuChem, Inc.
zuChem, Inc. Wholesale DistributorsDistribution Services zuChem, Inc. manufactures and supplies glycochemicals for the pharmaceutical, food and related industries. Its products include natural polyols, rare sugars and carbohydrates. Its glycochemicals are key components of many drugs and drug candidates as well as many specialty food ingredients. The company was founded by David C. Demirjian in 2001 and is headquartered in Chicago, IL. | Wholesale Distributors | Director/Board Member | |
Advanced Medical Technology Association
Advanced Medical Technology Association Miscellaneous Commercial ServicesCommercial Services Advanced Medical Technology Association is a trade association which provides medical technology solutions. The company was founded in 1974 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
CoreTechs Corp. | Chief Executive Officer | ||
Combimatrix Molecular Diagnostics, Inc. | Director/Board Member | ||
International University of Health Sciences | College/University | Corporate Officer/Principal | |
UniMedica, Inc. | Chairman | ||
CONTRAFECT CORPORATION | Biotechnology | Founder | |
Etubics Corp.
Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Baystar Biosciences | Director/Board Member | ||
Medezrin Ltd. | Director/Board Member | ||
Medisync Midwest LLC
Medisync Midwest LLC Miscellaneous Commercial ServicesCommercial Services Medisync Midwest LLC provides consultation services. It offers practice management partnership, clinical research, volume to value planning, diagnostic assessments, and HCC program. The company is headquartered in Cincinnati, OH. | Miscellaneous Commercial Services | Director/Board Member | |
Higuchi Bioscience Center | Director/Board Member | ||
CardioProfile, Inc. | Founder | ||
American Heyer-Schulte | President | ||
International Opera Alliance
International Opera Alliance Miscellaneous Commercial ServicesCommercial Services International Opera Alliance is an entertainment company focused on musical and arts activities. The company is headquartered in Fairfax, VA. | Miscellaneous Commercial Services | Director/Board Member | |
Players Club | Corporate Officer/Principal | ||
OHK Medical Devices, Inc.
OHK Medical Devices, Inc. Medical SpecialtiesHealth Technology OHK Medical Devices, Inc. develops and manufactures self-contained, sterile, exsanguinating tourniquet products. Its products include hand and wrist, foot and ankle, upper extremity, lower extremity and pediatrics. The company was founded by Noam Gavriely in 1999 and is headquartered in Grandville, MI. | Medical Specialties | Director/Board Member | |
Dalyda Finance LLC | Corporate Officer/Principal | ||
MEDITE CANCER DIAGNOSTICS INC | Medical Specialties | Director/Board Member | |
Hadean Ventures AS
Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway. | Investment Managers | Private Equity Investor | |
Pattern Pharma, Inc.
Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Vagelos College of Physicians & Surgeons | College/University | Doctorate Degree | |
Oncolyze, Inc.
Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Biotechnology | Founder |
Statistics
International
United States | 44 |
Canada | 3 |
United Kingdom | 3 |
Ireland | 2 |
Saint Kitts and Nevis | 2 |
Sectoral
Health Technology | 21 |
Consumer Services | 8 |
Commercial Services | 7 |
Finance | 4 |
Electronic Technology | 3 |
Operational
Director/Board Member | 40 |
Corporate Officer/Principal | 14 |
Chairman | 12 |
Independent Dir/Board Member | 9 |
Founder | 8 |
Most connected contacts
Insiders | |
---|---|
John H. Abeles | 33 |
Thomas M. Loarie | 18 |
Clinton H. Severson | 11 |
Nelson L. Levy | 9 |
Jenett Bruce | 2 |
Sam Kongsamut | 1 |
Yanhui Ma | 1 |
- Stock Market
- Insiders
- Paul A. Wender
- Company connections